Ewell Patrick Eagan - May 9, 2023 Form 4 Insider Report for VIEMED HEALTHCARE, INC. (VMD)

Role: General Counsel
Signature: /s/ Jesse Bergeron, Attorney-in-Fact
Stock symbol: VMD
Transactions as of: May 9, 2023
Transactions value $: -$1,050
Form type: 4
Date filed: 5/11/2023, 04:34 PM
Previous filing: Jan 20, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VMD	Common Shares	Options Exercise		+100	+4.42%		2.36K	May 9, 2023	Direct	F1
transaction	VMD	Common Shares	Disposed to Issuer	-$1.05K	-100	-4.24%	$10.50	2.26K	May 9, 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VMD	Phantom Share Units	Options Exercise	$0	-100	-50%	$0.00	100	May 9, 2023	Common Shares	100		Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one share of the Company's common shares. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash.
F2	Each share of phantom stock represents a right to receive the cash value of one share of the Issuer's common shares which will be determined based on the Issuer's share price on the vesting date.
F3	Represents an award granted in 2021 under the Issuer's Phantom Share Unit Plan which vests in equal installments on May 9, 2023 and May 9, 2024, subject to the Reporting Person's continued employment with the Issuer on such vesting date.